Boston Scientific (BSX) Stock Price, Fundamentals & Analysis
Price
44.62 USD
-0.67%
Price history
Over the past year BSX traded between 42.63 USD and 104.98 USD, closing at 44.62 USD on Sep 24, 2026.
Key statistics
| Market cap | 64.66B USD |
|---|---|
| P/E ratio (TTM) | 18.1 |
| Forward P/E | 13 |
| EPS (TTM) | 2.47 USD |
| Dividend yield | 0% |
| Annual dividend | 0 USD |
| Payout ratio | 0% |
| 52-week range | 42.2 – 105.65 |
| 52-week change | -54.2% |
| Beta | 0.57 |
| Price / book | 2.59 |
| Revenue (TTM) | 21B USD |
| Revenue growth (YoY) | 7.5% |
| Gross margin | 69.2% |
| Operating margin | 22.9% |
| Profit margin | 17.5% |
| Return on equity | 15.3% |
| Debt / equity | 50.2 |
| Volume | 18,400,825 |
| Average volume | 20,774,109 |
| Next earnings | Oct 28, 2026 |
| Exchange | NYSE |
Profile
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 59,000
- Headquarters
- Marlborough, United States
- Website
- bostonscientific.com
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems.
Overview
What BSX does
Boston Scientific (BSX) is a US stock in the Healthcare sector, specifically the Medical Devices industry, headquartered in Marlborough, United States. The company develops, manufactures, and markets medical devices used in interventional procedures worldwide. It operates across two segments, MedSurg and Cardiovascular, offering products ranging from diagnostic and therapeutic devices for gastrointestinal conditions to tools for treating urological and neurological disorders.
Key numbers explained
- The current share price is 44.62 USD, reflecting the latest trading value.
- The trailing P/E ratio of 18.1 shows how much investors pay per dollar of past earnings; a lower P/E ratio can suggest a stock is cheaper relative to its earnings.
- The forward P/E ratio of 13 uses expected future earnings, often seen as a more forward-looking valuation metric.
- Earnings per share over the trailing 12 months is 2.47 USD, representing the portion of profit allocated to each share.
- The dividend yield is 0%, meaning the company currently pays no cash dividend to shareholders.
- Beta of 0.57 indicates the stock has historically been less volatile than the overall market.
- Market capitalisation stands at 64.66B USD, classifying it as a large-cap company.
- The price-to-book ratio of 2.59 compares the market price to the company's book value per share.
Recent news
Recent headlines note that Boston Scientific (BSX) stock moved 2.74%, prompting analysis of what investors should know. Another piece examines how far BSX can swing after losing more than half its value over the past year. Other headlines include a new AI architecture launch by Ammonix, an FDA approval for Cordis involving a sirolimus-eluting balloon, and a list of value stocks with potential.
What to watch
For a stock like Boston Scientific, investors typically monitor medical device regulatory approvals, product cycle launches, and competitive dynamics within the Healthcare sector. Broader factors such as interest rate changes, healthcare policy shifts, and currency movements can also influence performance. As a component of the S&P 500, its movements may reflect wider market sentiment. Comparing it with peers like HCA Healthcare (HCA), Illumina, Inc. (ILMN), West Pharmaceutical Services (WST), Becton Dickinson (BDX), Waters Corporation (WAT), Intuitive Surgical (ISRG), and Cooper Companies (The) (COO) can provide sector context.
Latest news & filings
- Boston Scientific (BSX) Stock Moves 2.74%: What You Should Know
Zacks · Sep 22, 2026
- How Far Can BSX Stock Swing After Losing More Than Half Its Value?
Trefis · Sep 22, 2026
- Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
PR Newswire · Sep 22, 2026
- Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
PR Newswire · Sep 22, 2026
- Cordis wins FDA approval for sirolimus-eluting balloon
MedTech Dive · Sep 22, 2026
- 2 Value Stocks with Exciting Potential and 1 We Avoid
StockStory · Sep 22, 2026
- Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?
Zacks · Sep 21, 2026
- Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating
MT Newswires · Sep 21, 2026
- New Strong Sell Stocks for September 21st
Zacks · Sep 21, 2026
- GE Aerospace Goes Vertical (Integration)
Motley Fool · Sep 20, 2026
Frequently asked questions
Does BSX pay a dividend?
No, the current dividend yield is 0%, and 0% of earnings are paid out as dividends.
What is the BSX P/E ratio?
The trailing P/E ratio is 18.1, while the forward P/E ratio based on expected earnings is 13.
Where can I buy BSX?
BSX trades on the US market, so you can buy it through any brokerage that offers access to US stocks.
What does Boston Scientific do?
It develops, manufactures, and markets medical devices for interventional specialties worldwide, operating in MedSurg and Cardiovascular segments.
How volatile is BSX compared to the market?
Its beta of 0.57 suggests it has been less volatile than the overall market.
Related
More on BSX
Track BSX in your portfolio
Hold BSX at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free